The MGI product portfolio offers a comprehensive range of solutions designed to advance genomics research and clinical applications. MGI's products include sequencing platforms, reagents, and bioinformatics tools, all of which are developed with a focus on innovation, quality, and user accessibility. These products are designed to meet the diverse needs of the scientific community, from basic research to complex clinical diagnostics.

MGI's commitment to innovation is evident in its development of cutting-edge technologies like DNBSEQ, which enhances the accuracy and efficiency of DNA sequencing. In addition to sequencing platforms, MGI offers a variety of other products that support the entire sequencing workflow, including sample preparation kits, sequencing reagents, and data analysis software.

By providing high-quality products at competitive prices, MGI is making advanced genomics technologies more accessible to researchers and clinicians worldwide. This commitment to accessibility is helping to drive forward research in genetics, leading to new discoveries and innovations that benefit society as a whole.